Biopharma Collaboration (DxPP)

About First Ascent Medical

First Ascent Biomedical is a private, pre-revenue biotech startup pioneering a functional precision medicine platform for oncology. Its xDRIVE system tests up to 150+ FDA-approved drugs and combinations directly on a patient's live cancer cells (from solid or liquid tumors), integrating this functional data with genomics and AI to generate personalized treatment recommendations. The company targets three customer segments: patients/oncologists seeking alternative options, pharmaceutical companies for drug development, and research institutions. Validated through collaborations with top cancer centers, its platform promises to shift cancer care from standardized protocols to individualized treatment plans.

Therapeutic Areas